| |
BioReliance Corporation announces that its Rockville facilities and staff have been significantly expanded to accommodate the growing demand for its genetic toxicology (Gene Tox) testing services.
Click here to read the
press release.
Darryl L. Goss joins Bioreliance
Darryl L. Goss has been appointed Vice
President, Toxicology/Laboratory Animal Diagnostic Services (LADS), a new executive position created to lead this newly
formed Business Unit.
Click here to read the
press release.
|
|
|
|
|
BioReliance offers mammalian and microbial cell line development services for bioproduction of recombinant protein therapeutics.
Our offerings range from early vector development, establishment of a stable cell line, media adaptation and optimization for growth and protein expression, scale-up and stability analysis all leading to the production of a high-yield cGMP cell bank that is fully tested and characterized by our testing group. Additional services include process development for upstream cell culture as well as downstream product recovery. BioReliance will successfully transfer your process to a contract manufacturing service for bioproduction of clinical material.
Back to manufacturing services. |
 |
|
|
